17.11

1.07% -0.1853

Voyager Acquisition Corp (VACH)

Überblick Nachrichten Preisverlauf Forum Prognose

Schlusskurs vom Vortag:

$17.30

Offen:

$14.63

24-Stunden-Volumen:

12,135

Relative Volume:

0.68

Marktkapitalisierung:

$541.25M

Einnahmen:

Nettoeinkommen (Verlust:

$6.74M

KGV:

79.90

EPS:

0.2142

Netto-Cashflow:

$-412.70K

1W Leistung:

+61.46%

1M Leistung:

+56.87%

6M Leistung:

+62.07%

1J Leistung:

+65.12%

1-Tages-Spanne:

$13.17

$17.42

1-Wochen-Bereich:

$10.50

$18.16

52-Wochen-Spanne:

$8.40

$18.16

Voyager Acquisition Corp Stock (VACH) Company Profile

Firmenname

Voyager Acquisition Corp

Sektor

Financial (5954)

Branche

Shell Companies (366)

Telefon

03477204333

Adresse

C/O WINSTON & STRAWN LLP, HOUSTON

Mitarbeiter

Twitter

Nächster Verdiensttermin

Neueste SEC-Einreichungen

VACH's Discussions on Twitter

Compare VACH vs LION, XXI, UMAC, DMII, BCSS

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
VACH Voyager Acquisition Corp	17.11	541.25M	0	6.74M	-412.70K	0.2142
LION Lionsgate Studios Corp	13.95	3.98B	2.63B	-175.60M	11.40M	-0.7173
XXI Twenty One Capital Inc	5.74	1.85B	0	4.35M	456.40K	0.3397
UMAC Unusual Machines Inc	26.09	1.09B	17.25M	-5.64M	-40.16M	-0.3337
DMII Drugs Made In America Acquisition Ii Corp	10.08	642.73M	0	8.58M	-1.11M	0.134
BCSS Bain Capital Gss Investment Corp	10.23	596.27M	0	8.29M	-686.50K	0.142

Voyager Acquisition Corp Aktie (VACH) Neueste Nachrichten

01:57 AM

VERAXA Biotech Begins Trading on Nasdaq After Completing Business Combination - citybuzz -

01:57 AM

01:47 AM

VERAXA Biotech (NASDAQ: VRXA) Completes Business Combination, Begins Trading on Nasdaq - TipRanks

01:47 AM

04:16 AM

Heidelberg-based Veraxa ventures onto Nasdaq in turbulent market environment - European Biotechnology Magazine

04:16 AM

Jun 10, 2026

VERAXA Biotech to Debut as a Publicly Traded Company Pioneering Next-Generation Cancer Therapies on June 11, 2026 - The Manila Times

Jun 10, 2026

VERAXA Biotech to Debut as a Publicly Traded Company Pioneering Next-Generation Cancer Therapies on June 11, 2026 - Benzinga

Jun 10, 2026

[25-NSE] Voyager Acquisition Corp./Cayman Islands SEC Filing - Stock Titan

Jun 10, 2026

Voyager Acquisition CorpClass A Ordinary Shares (Nasdaq:VACH) Stock Quote - FinancialContent

Jun 10, 2026

Veraxa Biotech begins Nasdaq trading with $77.5 million financing - scanx.trade

Jun 10, 2026

Jun 09, 2026

Voyager Acquisition Corp Unit (VACHU) Surges 8.21% as SPAC Unit Approaches ResistanceBuffered ETF - newsline.com

Jun 09, 2026

Voyager Acquisition Corp Warrants (VACHW) Surge 7.89% as Speculative Interest ReturnsHigh Conviction Picks - newsline.com

Jun 09, 2026

Jun 08, 2026

Financials Sector: Companies, Performance and Stocks - TradingKey

Jun 08, 2026

Jun 07, 2026

UniCredit SpA (UCG) - MSN

Jun 07, 2026

May 29, 2026

Voyager Acquisition Corp Warrants (VACHW) Hold Steady at $0.15 Amid Low VolatilityValue Area Low - The Legal Advocate

May 29, 2026

Voyager Acquisition Corp Warrants (VACHW) Steady at $0.15 as Warrants Consolidate Between Key LevelsFRAMA Signal - The Legal Advocate

May 29, 2026

Voyager Acquisition Arranges $27.5M Secured Notes, Warrants and $50M Equity Facility With Lincoln Park - TradingView

May 29, 2026

Voyager Acquisition (NASDAQ: VACH) inks $27.5M note and $50M Veraxa share deal - Stock Titan

May 29, 2026

May 28, 2026

VERAXA Biotech Announces $27.5M Note Financing and $50M Share Purchase Agreement - citybiz

May 28, 2026

VERAXA Biotech AG Secures Capital and Seeks Nasdaq Listing - HarianBasis.co

May 28, 2026

VERAXA Biotech Secures $27.5M Financing, to Go Public Via SPAC - Yahoo Finance

May 28, 2026